Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: Implications for schizophrenia?

Biological Psychiatry

Volumn 44, Issue 11, 1998, Pages 1143-1150

  Csernansky, John G ^a,b   Csernansky, Cynthia A ^a   Kogelman, Laura ^a   Montgomery, Estelle Marie ^a,b   Bardgett, Mark E ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Hippocampus; Immunohistochemistry; Kainic acid; Neurodegeneration; Schizophrenia

Indexed keywords

KAINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIMBIC CORTEX; MALE; NERVE DEGENERATION; NERVE INJURY; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMALS; CEREBRAL VENTRICLES; COGNITION DISORDERS; HIPPOCAMPUS; KAINIC ACID; LIMBIC SYSTEM; MALE; NERVE DEGENERATION; RATS; SCHIZOPHRENIA; TIME FACTORS;

EID: 0032403733     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00019-5     Document Type: Article

References (40)

1. Akai F., Yanagihara T. Identity of the dorsal hippocampal region most vulnerable to cerebral ischemia. Brain Res. 603:1993;87-95.
2. Bardgett M.E., Csernansky J.G. Antipsychotic drugs and neuronal injury. Csernansky J.G. Antipsychotics (Handbook of Experimental Pharmacology, vol 120). 1996;267-288 Springer-Verlag, Berlin.
3. Bardgett M.E., Jackson J.J., Taylor G.T., Csernansky J.G. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens An animal model of schizophrenia . Behav Brain Res. 70:1995;153-164.
4. Bardgett M.E., Jacobs P.J., Jackson J.L., Csernansky J.G. Kainic acid lesions enhance locomotor responses to stress, amphetamine, and MK-801. Behav Brain Res. 84:1997;47-55.
5. Bardgett M.E., Jackson J.L., Harding J., Csernansky J.G. The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapine. Psychopharmacology. 113:1997;142-151.
6. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in the interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 48:1991;996-1001.
7. Buchanan R.W., Holstein C., Breier A. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance. Biol Psychiatry. 36:1994;717-725.
8. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
9. Condorelli D.F., Belluardo N., Mudo G., Dell'Albani P., Jiang X., Giuffrida-Stella A.-M. Changes in gene expression of AMPA-selective glutamate receptor subunits induced by status epilepticus in rat brain. Neurochem Int. 25:1994;367-376.
10. Davidson M., Haroutunian V. Cognitive impairment in geriatric schizophrenic patients Clinical and postmortem characterization . Bloom F.E., Kupfer D.J. Psychopharmacology The Fourth Generation of Progress . 1994;1447-1459 Raven Press, New York.
11. Feinberg I. Schizophrenia Caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res. 17:1982;319-330.
12. Filipkowski R.K., Hetman M., Kaminska B., Kaczmarek L. DNA fragmentation in rat brain after intraperitoneal administration of kainate. Neuroreport. 5:1994;1538-1540.
13. A receptor gene expression in adult rat hippocampus An in situ hybridation study . J Neurosci. 14:1994;2697-2707.
14. Gass P., Herdegen T., Bravo R., Kiessling M. Spatiotemporal induction of immediate early genes in the rat brain after limbic seizures Effects of NMDA receptor antagonist MK-801 . Eur J Neurosci. 5:1993;933-943.
15. Gellman R.L., Aghajanian G. Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res. 600:1993;63-73.
16. Gillardon F., Wickert H., Zimmerman M. Up-regulation of bax and down-regulation of bcl-2 is associated with kainate-associated apoptosis in mouse brain. Neurosci Lett. 192:1995;85-88.
17. Jeste D.V., Lohr J.B. Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry. 46:1989;1019-1024.
18. Johnson E.M., Greenlund L.J.S., Akins P.T., Hsu C.Y. Neuronal apoptosis Current understanding of molecular mechanisms and potential role in ischemic brain injury . J Neurotrauma. 12:1995;843-852.
19. Keefe R.S.E., Frescka E., Apter S.E., Davidson M., Macaluso J.M., Hirschowitz J., et al. Clinical characteristics of Kraepelinian schizophrenia Replication and extension of previous findings . Am J Psychiatry. 153:1996;806-811.
20. Kleinman J.E., Casanova M.F., Jaskiw G.E. The neuropathology of schizophrenia. Schizophr Bull. 14:1988;209-216.
21. Knowles W.D. Normal anatomy and neurophysiology of the hippocampal formation. J Clin Neurophysiol. 9:1992;252-263.
22. Kraepelin E. Lectures on Clinical Psychiatry. 1904;Baillere, Tendall and Cox, London.
23. Lowenstein D.H., Gwinn R.P., Seren M.S., Simon R.P., McIntosh T.K. Increased expression of mRNA encoding calbindin-D28K, the glucose-regulated proteins, or the 72 kDA heat-shock protein in three models of acute CNS injury. Mol Brain Res. 22:1994;299-308.
24. Magloczky Z.S., Freund T.F. Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfield. Neuroscience. 66:1995;847-860.
25. Margolis R.L., Chaung D.M., Post R.M. Programmed cell death Implications for neuropsychiatric disorders . Biol Psychiatry. 35:1994;946-956.
26. Massamiri T., Khrestchatisky M., Ben-Ari Y. Induction of c-fos mRNA expression in an in vitro hippocampal slice model of adult rats after kainate but not γ-aminobutyric acid or bicuculline treatment. Neurosci Lett. 166:1994;73-76.
27. McDonald J.W., Johnston M.V. Physiologic and patholphysiological roles of excitatory amino acids during central nervous development. Brain Res Rev. 15:1990;41-70.
28. Meltzer H.Y. Dimensions of outcome with clozapine. Br J Psychiatry. 160:(suppl 17):1992;46-53.
29. Nadler J.V., Perry B.W., Cotman C.W. Preferential vulnerability of hippocampus to intraventricular kainic acid. McGeer E.G., Olney J.W., McGeer P.L. Kainic Acid as a Tool in Neurobiology. 1978;219-237 Raven Press, New York.
30. Olney J.W., Rhee V., Ho O.L. Kainic acid A powerful neurotoxic analogue of glutamate . Brain Res. 77:1974;507-512.
31. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. 1986;Academic Press, Sydney.
32. Planas A.M., Soriango M.A., Ferrer I., Farre E.R. Kainic acid-induced heat shock protein-70, mRNA and protein expression is inhibited by MK-801 in certain rat brain regions. Eur J Neurosci. 7:1995;293-304.
33. Pollard H., Charriaut-Marlangue C., Cantagrel S., Represa A., Robain O., Moreau J., et al. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience. 63:1994;7-18.
34. Roberts G.W. Schizophrenia The cellular biology of a functional psychosis . Trends Neurosci. 13:1990;207-211.
35. Schreiber S.S., Tocco G., Najm I., Thompson R.F., Baudry M. Cycloheximide prevents kainate-induced neuronal death and c-fos expression in adult rat brain. J Mol Neurosci. 4:1993;149-159.
36. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. Arch Gen Psychiatry. 52:1995;805-818.
37. Silas-Santiago I., Greenlund L.J.S., Johnson E.M., Snider W.D. Molecular genetics of neuronal survival. Curr Biol. 5:1995;42-49.
38. Silverstein F.S., Torke L., Barks J., Johnston M.V. Hypoxia-ischemia produces focal disruption of glutamate receptors in developing brain. Dev Brain Res. 34:1987;33-39.
39. Verdoorn T.A., Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science. 252:1991;1715-1718.
40. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.